DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID ▼ | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0006826 | Malignant Neoplasms | CLEC18B | 497190 | C-type lectin domain family 18 member B | Q6UXF7 |
C0006826 | Malignant Neoplasms | TMED5 | 50999 | transmembrane p24 trafficking protein 5 | Q9Y3A6 |
C0006826 | Malignant Neoplasms | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
C0006826 | Malignant Neoplasms | PIK3CD | 5293 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | O00329 |
C0006826 | Malignant Neoplasms | ENPP3 | 5169 | ectonucleotide pyrophosphatase/phosphodiesterase 3 | O14638 |
C0006826 | Malignant Neoplasms | PIK3C2G | 5288 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma | O75747 |
C0006826 | Malignant Neoplasms | ISYNA1 | 51477 | inositol-3-phosphate synthase 1 | Q9NPH2 |
C0006826 | Malignant Neoplasms | PIK3C3 | 5289 | phosphatidylinositol 3-kinase catalytic subunit type 3 | Q8NEB9 |
C0006826 | Malignant Neoplasms | PIK3C2A | 5286 | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha | O00443 |
C0006826 | Malignant Neoplasms | ACSL5 | 51703 | acyl-CoA synthetase long chain family member 5 | Q9ULC5 |
C0006826 | Malignant Neoplasms | PLA2G2A | 5320 | phospholipase A2 group IIA | P14555 |
C0006826 | Malignant Neoplasms | PLCG1 | 5335 | phospholipase C gamma 1 | P19174 |
C0006826 | Malignant Neoplasms | SRGN | 5552 | serglycin | P10124 |
C0006826 | Malignant Neoplasms | AGK | 55750 | acylglycerol kinase | Q53H12 |
C0006826 | Malignant Neoplasms | PI4K2A | 55361 | phosphatidylinositol 4-kinase type 2 alpha | Q9BTU6 |
C0006826 | Malignant Neoplasms | PLD2 | 5338 | phospholipase D2 | O14939 |
C0006826 | Malignant Neoplasms | SMPD3 | 55512 | sphingomyelin phosphodiesterase 3 | Q9NY59 |
C0006826 | Malignant Neoplasms | ACSS2 | 55902 | acyl-CoA synthetase short chain family member 2 | Q9NR19 |
C0006826 | Malignant Neoplasms | PLCG2 | 5336 | phospholipase C gamma 2 | P16885 |
C0006826 | Malignant Neoplasms | ITLN1 | 55600 | intelectin 1 | Q8WWA0 |
C0006826 | Malignant Neoplasms | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0006826 | Malignant Neoplasms | NGLY1 | 55768 | N-glycanase 1 | Q96IV0 |
C0006826 | Malignant Neoplasms | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0006826 | Malignant Neoplasms | PRNP | 5621 | prion protein | P04156 |
C0006826 | Malignant Neoplasms | CMAS | 55907 | cytidine monophosphate N-acetylneuraminic acid synthetase | Q8NFW8 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024